Is ACHL or QYLD a better dividend investment in 2026?

ACHL currently yields 135.14% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: ACHL offers higher current income.

What is the dividend yield difference between ACHL and QYLD?

ACHL has a forward dividend yield of 135.14% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 123.22 percentage points.

Home › Compare › ACHL vs QYLD

ACHL vs QYLD: Dividend Comparison 2026

ACHL yields 135.14% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ACHL wins by $14.87M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ACHL

● Live price

135.14%

Share price

$1.48

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$14.90M

Annual income

$6,066,079.91

Full ACHL calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — ACHL vs QYLD

📍 ACHL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ACHL	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ACHL + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ACHL pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACHL

Annual income on $10K today (after 15% tax)

$11,486.49/yr

After 10yr DRIP, annual income (after tax)

$5,156,167.92/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, ACHL beats the other by $5,151,357.51/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACHL + QYLD for your $10,000?

ACHL: 50%QYLD: 50%

100% QYLD50/50100% ACHL

Portfolio after 10yr

$7.46M

Annual income

$3,035,869.62/yr

Blended yield

40.69%

📊

Analyst Conviction Gap

Where Wall Street is split right now

ACHL

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$2.00

+35.1% upside vs current

Range: $2.00 — $2.00

Altman Z

-2.7

Piotroski

1/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACHL buys

QYLD buys

No recent congressional trades found for ACHL or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricACHLQYLD

Forward yield	135.14% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$14.90M	$25.4K ✓
Annual income after 10y	$6,066,079.91 ✓	$5,659.31
Total dividends collected	$13.68M	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ACHL vs QYLD ($10,000, DRIP)

Year	ACHL Portfolio	ACHL Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$24,214	$13,513.51	$10,352	$1,192.36	+$13.9K → ACHL
2	$56,489	$30,580.34	$10,830	$1,347.57	+$45.7K → ACHL
3	$127,118	$66,675.01	$11,460	$1,539.07	+$115.7K → ACHL
4	$276,241	$140,224.56	$12,275	$1,777.84	+$264.0K → ACHL
5	$580,365	$284,787.59	$13,323	$2,078.95	+$567.0K → ACHL
6	$1,180,170	$559,178.96	$14,667	$2,463.34	+$1.17M → ACHL
7	$2,325,480	$1,062,698.63	$16,396	$2,960.57	+$2.31M → ACHL
8	$4,445,281	$1,957,016.59	$18,631	$3,612.97	+$4.43M → ACHL
9	$8,252,658	$3,496,207.78	$21,548	$4,482.15	+$8.23M → ACHL
10	$14,896,424	$6,066,079.91	$25,398	$5,659.31	+$14.87M → ACHL

ACHL vs QYLD: Complete Analysis 2026

ACHL — Stock

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. The company was founded in 2016 and is headquartered in London, the United Kingdom.

Full ACHL Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this ACHL vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACHL vs SCHD ACHL vs JEPI ACHL vs O ACHL vs KO ACHL vs MAIN ACHL vs XYLD ACHL vs JEPQ ACHL vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.